Prevention and Treatment of Venous Thromboembolism and Pulmonary Embolism: The Role of Novel Oral Anticoagulants

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|7|3|175-194

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.7, Iss.3, 2012-08, pp. : 175-194

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of Venous Thromboembolism with New Oral Anticoagulants versus Standard Pharmacological Treatment in Acute Medically Ill Patients: A Systematic Review and Meta-Analysis

By >   >   >   >   Lip Gregory Y.H.  

Drugs, Vol. 72, Iss. 13, 2012-09 ,pp. : 1755-1764

Adis International

Access to resources Recommend Favorite

New Oral Anticoagulants for Venous Thromboembolism: Focus on Factor Xa and Thrombin Inhibitors

By  

Current Drug Discovery Technologies, Vol. 9, Iss. 2, 2012-06 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

New Anticoagulants for the Prevention of Thromboembolism

By  

Current Pharmaceutical Design, Vol. 16, Iss. 31, 2010-10 ,pp. : 3472-3474

Bentham Science Publishers

Access to resources Recommend Favorite

The safety of fondaparinux for the prevention and treatment of venous thromboembolism

By Turpie Alexander GG  

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 707-721

Informa Healthcare

Access to resources Recommend Favorite

Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves

By Marcy Todd R.   Truong Teresa   Rai Andrea  

The Consultant Pharmacist, Vol. 30, Iss. 11, 2015-11 ,pp. : 644-656

American Society of Consultant Pharmacists

Access to resources Recommend Favorite